LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.60 | 27.76 | 1662 | 2235 | 0.7433 | 0.9085 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.60 | 27.76 | 1685 | 2235 | 0.7536 | 0.9126 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.60 | 27.76 | 2340 | 2235 | 1.0466 | 1.0144 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.60 | 27.76 | 2394 | 2235 | 1.0707 | 1.0217 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.30 | 27.76 | 1794 | 2449 | 0.7323 | 0.9059 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.30 | 27.76 | 1821 | 2449 | 0.7433 | 0.9103 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.30 | 27.76 | 2390 | 2449 | 0.9756 | 0.9924 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.30 | 27.76 | 2444 | 2449 | 0.9976 | 0.9993 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.01 | 27.76 | 1877 | 2662 | 0.7049 | 0.8965 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.01 | 27.76 | 1905 | 2662 | 0.7154 | 0.9008 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.01 | 27.76 | 2625 | 2662 | 0.9858 | 0.9957 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.01 | 27.76 | 2664 | 2662 | 1.0004 | 1.0001 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 37.71 | 27.76 | 1921 | 2877 | 0.6676 | 0.8829 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 37.71 | 27.76 | 1942 | 2877 | 0.6749 | 0.8859 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 37.71 | 27.76 | 2745 | 2877 | 0.9539 | 0.9860 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 37.71 | 27.76 | 2776 | 2877 | 0.9647 | 0.9893 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 39.41 | 27.76 | 2088 | 3105 | 0.6723 | 0.8867 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 39.41 | 27.76 | 2107 | 3105 | 0.6784 | 0.8892 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 39.41 | 27.76 | 2950 | 3105 | 0.9499 | 0.9850 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 39.41 | 27.76 | 2986 | 3105 | 0.9615 | 0.9885 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.11 | 27.76 | 2113 | 3331 | 0.6343 | 0.8724 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.11 | 27.76 | 2124 | 3331 | 0.6376 | 0.8738 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.11 | 27.76 | 3007 | 3331 | 0.9026 | 0.9706 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.11 | 27.76 | 3034 | 3331 | 0.9107 | 0.9731 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.81 | 27.76 | 2240 | 3596 | 0.6229 | 0.8695 | MN20160318_Q01 | C03 |